{
      "ptx_code": "PTX108",
      "chem_name": "Cyproterone acetate",
      "casrn": "427-51-0",
      "dtxsid": "DTXSID5020366",
      "smiles": "CC(=O)O[C@@]1(CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@]12C)C(C)=O",
      "inchikey": "UWFYSQMTEOIJJG-FDTZYFLXSA-N",
      "label": "PTX108 | Cyproterone acetate",
      "drugbank_id": "DB04839",
      "use_class": "Pharmaceutical",
      "tox_class": "Genotoxicity; Hepatotoxicity",
      "chem_name_user": "Cyproterone acetate",
      "mw_g_mol": "416.94",
      "solubility_h2o_mol_liter": "7.11701e-05",
      "source_solubility_h2o": "COMPTOX (OPERA)",
      "henry_coefficient_atm_m3_mol": "3.71754e-08",
      "source_henry": "COMPTOX",
      "log_kaw_kh_rt": "5.81805402169029",
      "source_kaw": "LSER eq 1 exp. Descriptors",
      "pka_acid": "",
      "pka_base": "",
      "source_pka": "ACD/GALAS",
      "log_kow_liter_liter": "3.9005",
      "source_kow": "",
      "log_dlipw_ph74_liter_liter": "4.68",
      "source_dlipw": "LSER",
      "freely_dissolved_fraction": "0.0188662466543747",
      "density_kg_liter": "",
      "source_density": "COMPTOX",
      "baseline_drerio": "3.8618908944899",
      "baseline_dmagna": "5.00913084574186",
      "baseline_celegans": "11.1640502390502",
      "baseline_xlaevis": "10.7516718281671",
      "baseline_dmelanogaster": "41.9411177084314",
      "baseline_cells": "2.87930611728799e-05",
      "baseline_cells_generic_micromole_liter_free_ec10": "5.4321699402205e-07",
      "moa_drugbank": "The direct antiandrogenic effect of cyproterone is blockage of the binding of dihydrotestosterone to the specific receptors in the prostatic carcinoma cell. In addition, cyproterone exerts a negative feed-back on the hypothalamo-pituitary axis, by inhibiting the secretion of luteinizing hormone resulting in diminished production of testicular testosterone.",
      "protein_binding": "",
      "moa_t3db": "",
      "aop": [
            {
                  "AOP_id": 19,
                  "AOP_name": "Androgen receptor antagonism leading to adverse effects in the male foetus (mammals) "
            },
            {
                  "AOP_id": 61,
                  "AOP_name": "NFE2L2/FXR activation leading to hepatic steatosis "
            }
      ],
      "targets": [
            "Androgen receptor",
            "Estrogen receptor alpha",
            "Glucocorticoid receptor",
            "Progesterone receptor"
      ]
}